Characteristic | Recurrence-free survival | Progression-free survival | ||||
---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||
p value | HR (95% CI) | p value | p value | HR (95% CI) | p value | |
Age | 0.095 | 0.523 | ||||
<70 years | ||||||
≥70 years | ||||||
Sex | 0.677 | 0.491 | ||||
Male | ||||||
Female | ||||||
Tumor grade | 0.593 | 0.424 | ||||
G1/2 | ||||||
G3 | ||||||
Concomitant CIS | 0.728 | 0.943 | ||||
Positive | ||||||
Negative | ||||||
Multifocality | 0.064 | 0.250 | ||||
Single | ||||||
Multiple | ||||||
History of Ta NMIBC | 0.694 | 0.079 | ||||
Recurrence | ||||||
Primary | ||||||
Lymphovascular invasion | 0.032 | 0.036 | 0.015 | 0.024 | ||
Positive | 2.19 (1.05–4.55) | 3.76 (1.19–11.90) | ||||
Negative |